Suicide without depression after withdrawal of a dopamine agonist in a patient with parkinson's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 23, Issue 4, 2011, Pages 32-

  Flament, Mélanie ^a   Loas, Gwenolé ^a   Godefroy, Olivier ^a   Krystkowiak, Pierre ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LEVODOPA; PRAMIPEXOLE;

ADULT; ANXIETY DISORDER; BECK HOPELESSNESS SCALE; CASE REPORT; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FALLING; HOPELESSNESS; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; JOGGING; LETTER; LIBIDO; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SUICIDAL IDEATION; SUICIDE; TREATMENT DURATION; TREATMENT WITHDRAWAL;

EID: 84858054053     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.23.4.e32     Document Type: Letter

References (3)

1. Weintraub D, Koester J, Potenza MN, et al: Impulse-control disorders in Parkinson disease: a cross-sectional study of 3,090 patients. Arch Neurol 2010; 67:589-595
2. Kolla BN, Mansukhani MP, Barraza R, et al: Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling. Psychosomatics 2010; 51:271-273
3. Kostic V, Pekmezovic T, Tomic A, et al: Suicide and suicidal ideation in Parkinson's disease. J Neurol Sci 2010; 289: 40-43